Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Nagoya
Clinical trial register · Japan

Clinical Trials in Nagoya, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Japan and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2493 matching records held by the registry are in this view. Synced 22 Oct 2026, 03:19 UTC
2493
Studies in scope
all four open statuses
1263
Recruiting now
open to new participants
349
Lead sponsors
across recruiting studies
Top sites
Chūōku 90 Fukuoka 84 Kashiwa 72 Bunkyō City 61 Kōtoku 56
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Merck Sharp & Dohme LLC53 AbbVie46 AstraZeneca36 Pfizer31 Novartis Pharmaceuticals30 Clear sponsor filter
Site location
Chūōku90 Fukuoka84 Kashiwa72 Bunkyō City61 Kōtoku56
All 186 locations
Target enrolment
to

Trials with a site in Nagoya

36 of 2493 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Japan
Start
Recruiting
AstraZeneca
Phase 3
750
Nagoya
2026-09-24
Recruiting
AstraZeneca
Phase 3
1,072
Kanazawa, Maebashi, Nagoya, Sapporo, Yokohama
2026-08-31
Recruiting
AstraZeneca
Phase 3
1,500
Aira, Chūōku, Fukuoka, Hachioji-shi, Izunokuni-shi, Kumamoto, Nagoya, Nerima-ku
2026-08-20
Recruiting
AstraZeneca
Phase 3
508
Bunkyō City, Kashiwa, Kyoto, Nagoya, Shibuya-ku, Shinjuku-ku
2026-02-23
Recruiting
AstraZeneca
Phase 3
1,100
Akashi-shi, Chūōku, Hidaka-shi, Kashiwa, Kobe, Kōtoku, Kurume-shi, Nagoya
2025-12-29
Recruiting
AstraZeneca
Phase 3
1,100
Chiba, Kashiwa, Kawasaki-shi, Kōtoku, Matsuyama, Nagoya, Osaka, Suita-shi
2025-12-04
Recruiting
AstraZeneca
Phase 2
100
Chūōku, Fukuoka, Hidaka-shi, Kashiwa, Kitaadachi-gun, Kōtoku, Nagoya, Osaka
2025-07-17
Recruiting
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
NCT06564038Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma, Mantle-cell Lymphoma, Large B-cell Lymphoma
DrugsSurovatamig·Acalabrutinib·Vincristine·Doxorubicin
AstraZeneca
Phase 1/2
408
Kōtoku, Matsuyama, Nagoya
2025-01-30
Active, closed
Phase IIa Study Evaluating AZD7798 in Crohn's Disease
NCT06450197Moderate to Severe Crohn's Disease
DrugAZD7798
AstraZeneca
Phase 2
120
Hiroshima, Kashiwa-shi, Kure-shi, Minatoku, Nagasaki, Nagoya, Sakura-shi, Sapporo
2024-08-28
Active, closed
AstraZeneca
Phase 3
339
Chūōku, Fukuoka, Kanazawa, Kita-gun, Nagoya, tabashi City, Wakayama, Yokohama
2024-06-29
Active, closed
AstraZeneca
Phase 3
594
Fukuoka, Kashiwa, Kōtoku, Nagoya, Ogaki-shi, Osaka, Sunto-gun, Tokyo
2024-03-04
Recruiting
Observational Study Protocol: LIVER-R
NCT06252753Hepatobiliary Cancers
AstraZeneca
Observational
4,000
Nagoya, Kashiwa-shi, Kurume, Kanazawa, Yokohama, Kyoto, Sendai, Ōsaka-sayama
2023-12-20
Recruiting
AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
NCT06219941Gastric Cancer, Gastroesophageal Junction Cancer, Biliary Tract Cancer, Pancreatic Ductal Adenocarcinoma
DrugsL-leucovorin·Nanoliposomal Irinotecan·Onivyde·Sonesitatug Vedotin
AstraZeneca
Phase 2
226
Chūōku, Kashiwa, Kitaadachi-gun, Kōtoku, Nagoya, Osakasayama-shi
2023-12-13
Recruiting
AstraZeneca
Phase 1/2
226
Kashiwa, Nagoya, Yamagata
2023-12-05
Active, closed
AstraZeneca
Phase 3
760
Hiroshima, Kashiwa, Kitaadachi-gun, Kōtoku, Mitaka-shi, Nagoya, Osaka, Sendai
2023-12-04
Active, closed
AstraZeneca
Phase 3
863
Amagasaki-shi, Hakodate-shi, Hiroshima, Kitaadachi-gun, Kitakyushu-shi, Matsuyama, Nagoya, Nishinomiya-shi
2023-11-09
Active, closed
AstraZeneca
Phase 3
314
Bunkyō City, Fukuoka, Iruma-Gun, Kanazawa, Maebashi, Nagasaki, Nagoya, Sapporo
2023-11-08
Active, closed
AstraZeneca
Phase 3
895
Bunkyō City, Fukuoka, Kashiwa, Kawasaki-shi, Kōtoku, Matsuyama, Nagoya, Okayama
2023-10-24
Active, closed
AstraZeneca
Phase 3
1,350
Bunkyō City, Chūōku, Hamamatsu, Hidaka-shi, Hirosaki-shi, Hiroshima, Kumamoto, Nagoya
2022-12-29
Active, closed
AstraZeneca
Phase 3
594
Bunkyō City, Chūōku, Kōtoku, Kurashiki-shi, Kurume-shi, Matsuyama, Nagoya, Niigata
2022-09-15
Recruiting
AstraZeneca
Phase 2
454
Chūōku, Kashiwa, Kōtoku, Nagoya, Shinagawa-ku, Suita-shi
2022-09-06
By invitation
AstraZeneca
Phase 3
214
Bunkyō City, Fukuoka, Kanazawa, Kōtoku, Nagoya, Okayama, Saga, Sunto-gun
2022-04-19
Active, closed
AstraZeneca
Phase 1/2
36
Nagoya, Setagaya City
2022-01-21
Active, closed
AstraZeneca
Phase 3
145
Minatoku, Nagoya, Shinjuku-ku
2021-11-19
Active, closed
AstraZeneca
Phase 3
927
Chūōku, Hidaka-shi, Hiroshima, Kawasaki-shi, Kōtoku, Nagoya, Ota-shi, Shinjuku-ku
2021-10-25
Active, closed
A Study of AZD0486 in Subjects With B-Cell Non-Hodgkin Lymphoma
NCT04594642B-cell Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Follicular Lymphoma
DrugSurovatamig
AstraZeneca
Phase 1
226
Chūōku, Kōtoku, Nagoya, Yamagata
2021-03-02
Active, closed
AstraZeneca
Phase 3
805
Chūōku, Kashiwa-shi, Kōtoku, Kurume-shi, Kyoto, Matsuyama, Minatoku, Nagoya
2020-05-05
Active, closed
AstraZeneca
Phase 2
247
Chūōku, Fukuoka, Kōtoku, Nagoya, Osaka, Wakayama
2019-06-25
Active, closed
AstraZeneca
Phase 2
367
Fukuoka, Hiroshima, Kanazawa, Nagoya, Niigata, Sapporo, Sayama, Sunto-gun
2019-01-09
Active, closed
AstraZeneca
Phase 3
1,407
Fukuoka, Kashiwa-shi, Kobe, Kōtoku, Kurume-shi, Kyoto, Minatoku, Nagoya
2019-01-04
Active, closed
AstraZeneca
Phase 2
401
Chūōku, Kanazawa, Kurume-shi,, Matsuyama, Nagoya, Sendai, Sunto-gun, Ube-shi
2018-12-21
Active, closed
AstraZeneca
Phase 3
825
Habikino-shi, Himeji-shi, Hiroshima, Iwakuni-shi, Kitaadachi-gun, Kitakyushu-shi, Kurashiki Shi, Nagoya
2018-12-06
Active, closed
AstraZeneca
Phase 3
724
Bunkyō City, Chiba, Chūōku, Fukuoka, Hiroshima, Kurume-shi, Musashino-shi, Nagoya
2018-11-30
Active, closed
AstraZeneca
Phase 3
730
Bunkyō City, Chūōku, Fukuoka, Iwakuni-shi, Kashiwa, Kōtoku, Kurume-shi, Nagoya
2018-09-27
Active, closed
AstraZeneca
Phase 3
216
Hiroshima, Kanazawa, Kashiwa, Nagoya, Niigata, Osaka, Sakaishi, Sapporo
2018-07-19
Active, closed
AstraZeneca
Phase 1
344
Chūōku, Habikino-shi, Hirakata-shi, Kashiwa, Nagoya
2014-08-05
Rows per page Showing 1–36 of 36
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Japanese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 22 October 2026. https://priyalifescience.com/clinical-trials-japan/city/nagoya

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Japan and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,493 studies in total at the last sync on 22 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 36 of those studies with a site in Nagoya that also match the filters currently applied.

How many clinical trials are recruiting in Nagoya?

12 of the 36 studies on this page are recruiting new participants as of the 22 Oct 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 23 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Nagoya), 36 studies
PhaseStudiesRecruitingShare
Phase 323663.9%
Phase 27319.4%
Phase 1/2328.3%
Phase 1205.6%
Observational112.8%

Most active sponsors

Lead sponsors with the most studies (Nagoya)
Lead sponsorStudiesRecruiting
AstraZeneca3612
→

Other trial registries in Japan

This register lists Japan studies from ClinicalTrials.gov. Many studies in Japan are registered only in a national registry. We do not copy those records; search them directly:

  • jRCT (Japan Registry of Clinical Trials) — run by the Ministry of Health, Labour and Welfare; trials under Japan's Clinical Trials Act and other clinical research
  • UMIN-CTR — run by the University of Tokyo Hospital's UMIN Center; many academic and investigator-led studies
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.